Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation.
Brain injuries are common in professional American football
players. Finding effective rehabilitation strategies can have widespread
implications not only for retired players but also for patients with
traumatic brain injury and substance abuse problems. An open label
pragmatic clinical intervention was conducted in an outpatient
neuropsychiatric clinic with 30 retired NFL players who demonstrated
brain damage and cognitive impairment. The study included weight loss
(if appropriate); fish oil (5.6 grams a day); a high-potency multiple
vitamin; and a formulated brain enhancement supplement that included
nutrients to enhance blood flow (ginkgo and vinpocetine), acetylcholine
(acetyl-l-carnitine and huperzine A), and antioxidant activity
(alpha-lipoic acid and n-acetyl-cysteine). The trial average was six
months. Outcome measures were Microcog Assessment of Cognitive
Functioning and brain SPECT imaging. In the retest situation, corrected
for practice effect, there were statistically significant increases in
scores of attention, memory, reasoning, information processing speed and
accuracy on the Microcog. The brain SPECT scans, as a group, showed
increased brain perfusion, especially in the prefrontal cortex, parietal
lobes, occipital lobes, anterior cingulate gyrus and cerebellum. This
study demonstrates that cognitive and cerebral blood flow improvements
are possible in this group with multiple interventions.
Keywords--brain trauma, football, MicroCog, rehabilitation, SPECT
Football players (Behavior)
Football players (Injuries)
Brain damage (Care and treatment)
Brain damage (Research)
Substance abuse (Care and treatment)
Substance abuse (Health aspects)
Brain (Care and treatment)
Amen, Daniel G.
Wu, Joseph C.
|Publication:||Name: Journal of Psychoactive Drugs Publisher: Taylor & Francis Ltd. Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2011 Taylor & Francis Ltd. ISSN: 0279-1072|
|Issue:||Date: March, 2011 Source Volume: 43 Source Issue: 1|
|Topic:||Event Code: 310 Science & research|
|Product:||Product Code: 8000143 Alcohol & Drug Abuse Programs NAICS Code: 62142 Outpatient Mental Health and Substance Abuse Centers SIC Code: 8093 Specialty outpatient clinics, not elsewhere classified|
|Geographic:||Geographic Scope: United States Geographic Code: 1USA United States|
Brain injuries are common in professional American football
players, and their incidence has been associated with mild cognitive
impairment, dementia and depression (Guskiewicz et al. 2007, 2005). A
study sponsored by the National Football League (NFL) found that retired
players aged 30 to 49 receive a dementia-related diagnosis at a rate of
1.9%, or 20 times the rate of age-matched populations, while 6.1% of
players over the age of 50 receive a dementia-related diagnosis
representing five times the national average of 1.2% (Weir, Jackson
& Sonnega 2009). In a recent study conducted on 100 active and
retired NFL players the authors found overall decreased cerebral
perfusion and a higher incidence of depression, obesity and memory and
attentional problems compared to the general population (Amen et al.
2011). In addition, brain injuries have also been found to increase the
risk of substance abuse (Olson-Madden et al. 2010; Graham & Caron
Brain injuries affect not only retired professional football players, but also an estimated 1.7 million people annually (CDC 2010) and many soldiers returning from Iraq and Afghanistan. In addition, substance abusers also experience high levels of brain damage from the toxic effects of the alcohol or other drugs or and the higher incidence of brain injuries during intoxication (Gold et al. 2009).
Evaluating potential treatments to rehabilitate or reverse brain damage is important in many clinical populations, especially for patients with traumatic brain injury and substance abuse. Brain SPECT imaging is a standard, widely available functional brain imaging tool that has been found to help evaluate baseline brain function and the effect of treatment interventions (Amen 2010). In this report we describe our experience with 30 retired NFL players who took part in a pragmatic open-label, clinical intervention to attempt to reverse brain damage and cognitive dysfunction.
MATERIALS AND METHODS
As part of a larger study we recruited 100 retired NFL players, representing 27 teams and all positions. Each player met our inclusion criteria of being on an active NFL roster for a minimum of three years. We excluded any subjects who could not cease taking psychoactive medications (recreational or otherwise) for an appropriate washout period prior to scanning. All subjects signed informed consent as part of an IRB protocol. The study started in 2009 and concluded in 2010.
Each participant was interviewed by a physician and completed a detailed medical and psychiatric history. Weight, height and waist size were obtained on all participants and body mass index (BMI) and waist-to-height ratios were calculated. As part of the evaluation each participant took the Microcog Assessment of Cognitive Functioning (MACF; Powell et al. 2004), which contains nine subtests: general cognitive functioning, general cognitive proficiency, information processing speed, information processing accuracy, attention, reasoning, memory, spatial processing and reaction time. The MACF scores were compared to its own standardized sample (n = 810) chosen to be representative of the U.S. population of adults between the ages of 18 and 89 in regards to education, gender, and ethnicity. The MACF was chosen because the means from test to retest were stable over time and showed little practice effect (Powell et al. 1993).
In addition, each subject underwent high-resolution brain SPECT imaging to measure regional cerebral blood flow (rCBF). Each subject received an age/weight-appropriate dose of Tc99m HMPAO intravenously. Subjects were injected in normal lighting while they performed a go, nogo, continuous performance task. The radiopharmaceutical was injected three minutes after starting the 15-minute test. All subjects completed the task. Subjects were then scanned 30 minutes later using a high-resolution Picker Prism 3000 triple-headed gamma camera with fan beam collimators, acquiring data in 128x128 matrices, yielding 120 images per scan with each image separated by 3 degrees spanning 360 degrees.
SPECT data were processed and attenuation correction performed using general linear (Chang) methods. All images were reconstructed and resliced using an oblique reformatting program, according to anterior-posterior commissure line so final images were similarly aligned for analysis.
All subjects were offered the opportunity to participate in a pragmatic interventional phase. Pragmatic interventions are ones that participants might experience in a "real-world" clinical situation. The interventions included education on a brain-healthy lifestyle, such as proper nutrition, regular exercise, limiting alcohol, eliminating drug abuse and cigarette smoking, getting appropriate sleep, and having sleep apnea assessed if symptoms were endorsed. As obesity has been associated with dementia and a smaller brain (Raji et al. 2010), we encouraged overweight or obese players to lose weight. Forty-eight percent of players in the initial study were overweight or obese, even taking into account their large body frames. Author KW ran an optional weight-loss group for players. In addition, players were given 5.6 grams of fish oil a day, containing 1720mg of EPA and 1160mg of DHA, as omega-three fatty acid supplementation has shown benefits with memory, mood and cognition (Michael-Titus 2009; Conklin et al. 2007) and a high-potency multiple vitamin, which has been shown to enhance mental performance (Kennedy et al. 2010). Participants in the interventional study also received a brain enhancement supplement that contained clinically effective dosages of nutrients to enhance blood flow: ginkgo (Santos et al. 2003) and vinpocetine (Gulyas et al. 2002); decrease cortisol: phosphatidylserine (Monteleone et al. 1990); enhance acetylcholine: acetyl-l-carnitine (Jones, McDonald & B orum 2010) and huperzine A (Zhang, Yan & Tang 2008); and enhance antioxidants: alpha-lipoic acid (Arguelles et al. 2010) and n-acetyl-cysteine (Dodd et al. 2008). The trial for each participant ranged from two to 12 months, with the average being six months, depending on the participant's ability to travel to the study location in Southern California.
In the follow-up evaluation, participants underwent a clinical interview, completed a questionnaire on their progress, had a follow-up brain SPECT scan, and retook the MACF.
SPECT Image Analysis
Differences in HMPAO uptake were analyzed using SPM8 software (Wellcome Department of Cognitive Neurology, London, UK) implemented on the Matlab platform (MathWorks Inc., Sherborn, MA). Statistical parametric maps (SPMs) are spatially extended statistical processes that are constructed to test hypotheses about regionally specific effects in neuroimaging data. Statistical parametric mapping combines the general linear model and the theory of Gaussian random fields to make statistical inferences about regional effects (Friston, Holmes & Worsley 1995). The images were spatially normalized using a twelve parameter affine transformation followed by nonlinear deformations (Ashburner & Friston 1999) to minimize the residual sum of squares between each scan and a reference or template image conforming to the standard space defined by the Montreal Neurological Institute (MNI) template. The original image matrix obtained at 128x128x29 with voxel sizes of 2.16mm x 2.16mm x 6.48mm were transformed and resliced to a 79x95x68 matrix with voxel sizes of 2mm x 2mm x 2mm consistent with the MNI template. Images were smoothed using an 8mm FWHM isotropic Gaussian kernel.
As a group, we compared participants' original SPECT scans with their follow-up scans using a paired t-test with ANCOVA. Based on our prior study (Amen et al. 2011), our hypothesis was that we would see increased rCBF in the prefrontal cortex, anterior cingulate gyrus, temporal lobes, parietal lobes, occipital lobes and cerebellum. SPM(z) score differences for a-priori regions of interest (Table 2) were computed using the WFU PickAtlas toolbox within the SPM8 framework (Maldjian, Laurienti & Burdette 2004; Maldjian et al. 2003).
In the retest situation, corrected for practice effect, there were statistically significant increases in MACF scores in general cognitive functioning, general cognitive proficiency, attention, memory, reasoning, information processing speed and accuracy (see Table 1). There were also increases in spatial processing and reaction time, although these were not statistically significant. Many of the participants had robust increases in performance. Table 1 also lists the number of participants in each category who had a greater than 50% increase in percentile scores.
The brain SPECT scans also showed significant increases in brain perfusion at p < 0.001, especially in the prefrontal cortex, anterior cingulate gyrus, parietal lobes, occipital lobes, and cerebellum (see Table 2 for specific areas of significant increases and Figure 1 for a visual representation of the areas of significant increase). No significant decreases were seen. These findings were consistent with our hypothesis, except at this level we did not see increases in temporal lobe perfusion. When the threshold was lowered to p < 0.05 there were significant increases in the left and right fusiform gyrus and lateral temporal lobes. Symptomatically, participants reported increases in memory (69%), attention (53%), mood (38%), motivation (38%), and sleep (25%).
[FIGURE 1 OMITTED]
This clinical study targeted retired professional football players who had experienced traumatic brain injuries as a result of numerous impacts over extended periods of time. Our goal was to design an interventional strategy that would improve cognitive function by enhancing cerebral blood flow, acetylcholine and antioxidant activity. We utilized a standard brain imaging tool (SPECT) and a standard computerized neuropsychological test (MACF) to determine if improvement could be obtained. Our findings on this unique population are encouraging as we observed significant improvements in general cognitive functioning, information processing speed, attention and memory in close to half of the participants. Plus, there were significant increases in regional cerebral blood flow seen on SPECT.
The implications of this study directly apply to the larger traumatic brain injury and substance abuse communities. We were able to demonstrate improvement in brain function and cognitive performance in retired players who sustained brain injuries often decades previously, demonstrating brain plasticity. This is an area where much more research is needed. Because of the high incidence of traumatic brain injury and the long-term damaging effects of substance abuse, focusing on brain health and brain rehabilitation strategies in addiction treatment programs could potentially significantly improve patient outcomes.
This clinical study is limited by its nonrandomized, open-label, multifaceted design and the results must be interpreted with caution. Our hope is to use this trial as a starting point to more rigorously study the individual parts of the treatment protocol and to extend the study to include other types of brain damage, including blast injuries, single-incident brain traumas, and those resulting from substance abuse.
Amen, D.G.; Newberg, A.; Thatcher, R.; Jin, Y.; Wu, J.; Keator, D. & Willeumier, K. 2011. The impact of playing professional American football on long-term brain function. Journal of Neuropsychiatry Clinical Neurosciences 23 (1): 98-106.
Amen, D.G. 2010. High resolution brain SPECT imaging in a clinical substance abuse practice. Journal of Psychoactive Drugs 42 (2): 153-60.
Arguelles, S.; Cano, M.; Machado, A. & Ayala, A. 2010. Comparative study of the in vitro protective effects of several antioxidants on elongation factor 2 under oxidative stress conditions. Bioscience, Biotechnology and Biochemistry July 7 [Epub ahead of print].
Ashburner, J. & Friston, K. 1999. Nonlinear spatial normalization using basis functions. Human Brain Mapping 7: 254-66.
Centers for Disease Control and Prevention (CDC). 2010. Traumatic Brain Injury. http://www.cdc.gov/traumaticbraininjury.
Conklin, S.M.; Gianaros, P.J.; Brown, S.M.; Yao, J.K.; Hariri, A.R.; Manuck, S.B. & Muldoon, M.F. 2007. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neuroscience Letters 421 (3): 209-12.
Dodd, S.; Dean, O.; Copolov, D.; Malhi, G.S. & Berk, M. 2008. N acetylcysteine for antioxidant therapy: Pharmacology and clinical utility. Expert Opinion on Biological Therapy 8 (12): 1955-62.
Friston, K.; Holmes, A. & Worsley, K. 1995. Statistical parametric maps in functional imaging: A general linear approach. Human Brain Mapping 2: 189-210.
Gold, M.S.; Kobeissy, F.H.; Wang, K.K.; Merlo, L.J.; Bruijnzeel, A.W.; Krasnova, I.N. & Cadet, J.L. 2009. Methamphetamine- and trauma-induced brain injuries: Comparative cellular and molecular neurobiological substrates. Biological Psychiatry 66 (2): 118-27.
Graham, D.P. & Cardon, A.L. 2008. An update on substance use and treatment following traumatic brain injury. Annals of the New York Academy of Sciences 1141: 148-62.
Gulyas, B.; Halldin, C.; Sandell J.; Karlsson, P.; Sovago, J.; Karpati, E.; Kiss, B.; Vas, A.; Cselenyi, Z. & Farde, L. 2002. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica 106 (6): 325-32.
Guskiewicz, K.M.; Marshall, S.W.; Bailes, J.; McCrea, M.; Harding, H.P Jr.; Matthews, A.; Mihalik, J.R. & Cantu, R.C. 2007. Recurrent concussion and risk of depression in retired professional football players. Medicine and Science in Sports & Exercise 39 (6): 903-09.
Guskiewicz, K.M.; Marshall, S.W.; Bailes, J.; McCrea, M.; Cantu, R.C.; Randolph, C. & Jordan, B.D. 2005. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 57 (4): 719-26.
Jones, L.; McDonald, D. & Borum, P. 2010. Acylcarnitines: Role in brain. Progress in Lipid Research 49 (1): 61-75.
Kennedy, D.; Veasey, R.; Watson, A.; Dodd, F.;; Jones, E.; Maggini, S. & Haskell, C.F. 2010. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berlin) 211 (1): 55-68.
Maldjian, J.; Laurienti, P. & Burdette, J. 2004. Precentral gyrus discrepancy in electronic versions of the talairach atlas. NeuroImage 21 (1): 450-55.
Maldjian, J.; Laurienti, P.; Burdette, J. & Kraft, R. 2003. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19 (3):1233-39.
Michael-Titus, A.T. 2009. Omega-3 fatty acids: Their neuroprotective and regenerative potential in traumatic neurological injury. Clinical Lipidology 4 (3): 343-53.
Monteleone, P.; Beinat, L. & Tanzillo, C.; Maj, M. & Kemali, D. 1990. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology 52 (3): 243-48.
Olson-Madden, J.H.; Brenner, L.; Harwood, J.E.; Emrick, C.D.; Corrigan, J.D. & Thompson, C. 2010. Traumatic brain injury and psychiatric diagnoses in veterans seeking outpatient substance abuse treatment. Journal of Head Trauma Rehabilitation Apr 20. [Epub ahead of print]
Powell, D.; Kaplan, E.; Whitla, D.; Weintraub, S. Catlin, R. & Funkenstein, H. 2004. MicroCog Assessment of Cognitive Functioning. Windows Edition. San Antonio, TX: Pearson.
Powell, D.; Kaplan, E.; Whitla, D.; Weintraub, S. Catlin, R. & Funkenstein, H. 1993. Manualfor MicroCog: Assessment of Cognitive Functioning. San Antonio, TX: The Psychological Corporation.
Raji, C.A.; Ho, A.J.; Parikshak, N.N.; Becker, J.T.; Lopez, O.L.; Kuller, L.H.; Hua, X.; Leow, A.D.; Toga, A.W. & Thompson, P.M. 2010. Brain structure and obesity. Human Brain Mapping 31 (3): 353-64.
Santos, R.F.; Galduroz, J.C.; Barbieri, A.; Castiglioni, M.L.; Ytaya, L.Y. & Bueno, O.F. 2003. Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using ginkgo biloba. Pharmacopsychiatry 4: 127-33.
Weir, D.R.; Jackson, J.S. & Sonnega, A. 2009. Study of Retired NFL Players. Ann Arbor: Institute for Social Research, University of Michigan. Available at http://www.ns.umich.edu/Releases/2009/ Sep09/FinalReport.pdf.
Zhang, H.; Yan, H. & Tang, X. 2008. Non-cholinergic effects of huperzine A: Beyond inhibition of acetylcholinesterase. Cellular and Molecular Neurobiology 28 (2): 173-83.
([dagger]) Players were recruited with the help of the Los Angeles Chapter of the Retired NFL Players Association, The Summit, and Dave Pear's blog. The authors wish to thank Anthony Davis, Marvin Smith, Reggie Berry, Dave Pear, Robert Lee and all the retired players for their assistance. No competing financial interests exist for any of the authors.
Daniel G. Amen, M.D., Assistant Clinical Professor, UC Irvine School of Medicine, Irvine, CA.
Joseph C. Wu, M.D., Associate Professor, UC Irvine School of Medicine; Clinical Director, Brain Imaging Center, UC, Irvine School of Medicine, Irvine, CA.
Derek Taylor, Data Analysis, Amen Clinics, Inc., Newport Beach, CA.
Kristen Willeumier, Ph.D., Research Director, Amen Clinics, Inc., Newport Beach, CA.
Please address correspondence and reprint requests to Daniel G. Amen, M.D., Amen Clinics, Inc., 4019 Westerly Place Suite 100, Newport Beach, CA 92660. Phone: 949-266-3717, fax: 949-266-3766, email: email@example.com
TABLE 1 Before and After Percentile Scores on the Microcog Assessment of Cognitive Functioning in 30 NFL Players Number of Before After Players MicroCog Mean Mean with >50% Domains (Std. Dev) (Std. Dev) p Value improvement General Cognitive Functioning 31.8 (24.1) 43.4 (25.7) <0.000 14 General Cognitive Proficiency 24.7 (20.1) 35.2 (23.5) <0.000 14 Processing Speed 33.1 (24.8) 39.3 (25.5) 0.026 12 Processing Accuracy 40.9 (28.7) 48.5 (29.1) 0.012 13 Attention 38.4 (26.2) 48.7 (27.6) 0.025 9 Reasoning 32.7 (25.7) 41.6 (28.0) 0.006 11 Memory 33.8 (27.4) 42.9 (28.4) 0.022 17 Spatial Processing 69.0 (21.8) 74.3 (13.2) 0.154 3 Reaction Time 70.2 (24.5) 74.67 (22.9) 0.669 6 TABLE 2 Significant Areas of Increased Perfusion After Treatment at p < 0.001 AAL Areas Cluster Size Location Z Prefrontal Infer-Mid-Sup Lt 473 -24 62 16 4.69 Prefrontal Mid Sup Rt 2064 36 50 24 3.58 Inferior Orbital Lt 244 -2 52 -32 4.05 Anterior Cingulate Rt 79 12 40 24 3.68 Parietal/Angular Lt 77 -60 -54 48 4.49 Parietal/Precuneus Lt 205 -12 -56 74 4.32 Parietal/Precuneus Rt 188 20 -54 78 4.35 Occipital/Cuneus Lt 136 2 -102 18 4.30 Occipital/Cuneus Rt 197 26 -104 8 3.89 Cerebellum Crus Rt 104 48 -78 -22 4.01
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|